HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Education
Visit Zacks' Education section
for investing guides and other free resources to make you a better investor.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

DSCM: Drugstore.com Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

DRUGSTORE.COM INC (NASD)
DSCM 2.78 -0.04 (-1.42%) Vol.  72,535 15:59 ET

Day Low - High 2.75 - 2.86
52wk Low - High 0.65 - 3.22
Avg Volume 313,971
Industry ELECTRONIC COMMERCE
Market Cap 277.68 M
Div - Yield 0.00 - 0.00
PE (forward)
PEG Ratio N/A
Current Year Est. -.03
EPS Last Year -0.07
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


upgraded 10/22/2009
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 10/22/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
DRUGSTORE.COM INC DSCM PREMIUM
CTRIP.COM INTL CTRP PREMIUM
EXPEDIA INC EXPE PREMIUM
BLUE NILE INC NILE PREMIUM
See all ELECTRONIC COMMERCE Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.67
ABR (Last Week) 1.67
# of Recs in ABR 4
Average Target Price 3.58
Industry Rank by ABR 38 out of 217
Rank in Industry 4 out of 20
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate DSCM?
Buy
Sell
Find out what the Zacks Community
thinks of DSCM at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR DSCM
Zacks Equity Research: Report for DSCM
Oct 22, 2009
Zacks Blog: drugstore.com, LoopNet, Research In Motion, Apple and Palm
May 04, 2009
Bull of the Day: drugstore.com (DSCM)
May 04, 2009
Zacks Blog: drugstore.com Strong, Long-Term
Feb 06, 2009
Zacks Blog: drugstore.com Strategy Embraced
Nov 10, 2008
More Zacks Commentary
NEWS
drugstore.com Guides Above Estimates
Oct 20, 2009
drugstore.com Reports Strong Revenue Growth and Record Gross Margins in the Third Quarter of 2009
Oct 20, 2009
Conference Calls Today: 12-1:30 P.M. EDT
Oct 20, 2009
drugstore.com, inc. to Announce Third Quarter 2009 Results During Conference Call On Tuesday, October 20, 2009 At 4:30 p.m. ET
Oct 06, 2009
SexualWellBeing.com Celebrates Grand Opening with Special Offer
Oct 01, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate -0.02 N/A -0.03 0.03
Number of Estimates 3 0 3 2
Low Estimates -0.02 N/A -0.05 0.01
High Estimate -0.01 N/A -0.01 0.04
Year Ago EPS -0.03 0.00 -0.10 -0.03
EPS Growth 44.44% N/A% 73.33% 193.75%

More Estimates

COMPANY DESCRIPTION
Drugstore.com is a leading online provider of health, beauty, vision, and pharmacy products. The drugstore.com online store provides a convenient, private, and informative shopping experience that encourages consumers to purchase products essential to healthy, everyday living. The online store offers thousands of brand-name personal health care products at competitive prices; a full-service, licensed retail pharmacy; and a wealth of health-related information, buying guides, and other tools designed to help consumers make informed purchasing decisions. Consumers can personalize their shopping experiences with shopping lists, e-mail reminders for replenishing regularly used products, and private e-mail access to pharmacists and beauty experts for questions.

Full Company Report
FINANCIALS
EPS TTM -.07
Sales 366.58
Net Income 1.01
Price/Earnings N/A
Price/Book 2.85
Price/Cash Flow 138.05
Price/Sales .71


More Financials

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research